loadpatents
name:-0.03231406211853
name:-0.018754959106445
name:-0.0054550170898438
LEE; Virginia M.Y. Patent Filings

LEE; Virginia M.Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEE; Virginia M.Y..The latest application filed is for "monoclonal antibodies against alpha-synuclein fibrils".

Company Profile
4.19.28
  • LEE; Virginia M.Y. - Philadelphia PA
  • Lee; Virginia M-Y - Philadelphia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monoclonal Antibodies Against Alpha-Synuclein Fibrils
App 20220135661 - LUK; Kelvin C. ;   et al.
2022-05-05
Monoclonal Antibodies Against Pathological Alpha-Synuclein, and Methods Using Same
App 20220041698 - LUK; Kelvin C. ;   et al.
2022-02-10
Monoclonal antibodies against alpha-synuclein fibrils
Grant 11,220,538 - Luk , et al. January 11, 2
2022-01-11
Monoclonal antibodies against pathological alpha-synuclein, and methods using same
Grant 11,155,608 - Luk , et al. October 26, 2
2021-10-26
[1,2,4]triazolo[1,5-a] Pyrimidine Compounds And Use In Stabilizing Microtubules
App 20200399269 - BRUNDEN; Kurt R. ;   et al.
2020-12-24
Monoclonal Antibodies Against Pathological Alpha-Synuclein, and Methods Using Same
App 20200369752 - LUK; Kelvin C. ;   et al.
2020-11-26
Monoclonal Antibodies Against Alpha-Synuclein Fibrils
App 20200062835 - LUK; Kelvin C. ;   et al.
2020-02-27
Heterocyclic Compounds And Their Use For The Treatment Of Neurodegenerative Tauopathies
App 20170173016 - Ballatore; Carlo ;   et al.
2017-06-22
Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
Grant 9,649,317 - Ballatore , et al. May 16, 2
2017-05-16
Cycloalkyl-dione derivatives and methods of their use
Grant 9,643,919 - Ballatore , et al. May 9, 2
2017-05-09
Cycloalkyl-dione Derivatives And Methods Of Their Use
App 20160031805 - BALLATORE; Carlo ;   et al.
2016-02-04
Heterocyclic Compounds And Their Use For The Treatment Of Neurodegenerative Tauopathies
App 20150224105 - Ballatore; Carlo ;   et al.
2015-08-13
Thromboxane A2 (TP) receptor antagonists
Grant 8,927,586 - Trojanowski , et al. January 6, 2
2015-01-06
Cell-Based Models of Neurodegenerative Disease
App 20130337463 - Brunden; Kurt R. ;   et al.
2013-12-19
Tau Acetylation in the Pathogenesis of Alzheimers Disease and Other Related Tauopathies
App 20130251731 - Lee; Virginia M.Y. ;   et al.
2013-09-26
Cycloalkyl-dione derivatives and methods of their use
Grant 8,530,520 - Atasoylu , et al. September 10, 2
2013-09-10
Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor
App 20130190370 - Trojanowski; John Q. ;   et al.
2013-07-25
Detection of Neurodegenerative Disease
App 20130184441 - Lee; Virginia M. Y. ;   et al.
2013-07-18
Amyloid plaque aggregation inhibitors and diagnostic imaging agents
Grant RE44,354 - Kung , et al. July 9, 2
2013-07-09
Novel Thromboxane A2 (TP) Receptor Antagonists
App 20130165488 - Trojanowski; John Q. ;   et al.
2013-06-27
Aminothienopyridazine Inhibitors Of Tau Assembly
App 20130029983 - Ballatore; Carlo ;   et al.
2013-01-31
Detection of neurodegenerative disease
Grant 8,354,236 - Lee , et al. January 15, 2
2013-01-15
Cycloalkyl-dione Derivatives And Methods Of Their Use
App 20120329877 - Atasoylu; Onur ;   et al.
2012-12-27
Antibody Treatment of Alzheimer's and Related Diseases
App 20100209417 - Lee; Virginia M.Y. ;   et al.
2010-08-19
Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
App 20100068308 - Phiel; Christopher J. ;   et al.
2010-03-18
Detection of Neurodegenerative Disease
App 20090263824 - Lee; Virginia M.Y. ;   et al.
2009-10-22
Regulation of GSK-3.alpha. activity for the treatment or prevention of Alzheimer's disease
Grant 7,378,111 - Phiel , et al. May 27, 2
2008-05-27
Compositions and methods for producing and using homogenous neuronal cell transplants
Grant 7,011,827 - Lee , et al. March 14, 2
2006-03-14
Compositions and methods for producing and using homogenous neuronal cell transplants
App 20060029575 - Lee; Virginia M-Y ;   et al.
2006-02-09
Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
App 20040110837 - Phiel, Christopher J. ;   et al.
2004-06-10
Transgenic animal expressing alpha-synuclein and uses thereof
App 20030217370 - Giasson, Benoit I. ;   et al.
2003-11-20
Administration Of An Agent Which Decreases Processing Of Amyloid Precursor Protein
App 20030186315 - LEE, VIRGINIA M.-Y. ;   et al.
2003-10-02
Diagnostic methods for Alzheimer's disease by detection of multiple mRNAs
App 20020102594 - Ginsberg, Stephen ;   et al.
2002-08-01
Diagnostic methods for alzheimer's disease by detection of multiple mRNAs
Grant 6,358,681 - Ginsberg , et al. March 19, 2
2002-03-19
Compositions and methods for producing and using homogenous neuronal cell transplants
App 20010052136 - Lee, Virginia M. Y. ;   et al.
2001-12-13
Diagnostic Methods For Alzheimer's Disease By Detection Of Multiple Mrnas
App 20010026916 - GINSBERG, STEPHEN ;   et al.
2001-10-04
Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries
Grant 6,214,334 - Lee , et al. April 10, 2
2001-04-10
Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
Grant 5,733,734 - Trojanowski , et al. March 31, 1
1998-03-31
Method of detecting abnormally phosphorylated tau(.tau.)
Grant 5,601,985 - Trojanowski , et al. February 11, 1
1997-02-11
Method of stabilizing microtubules
Grant 5,580,898 - Trojanowski , et al. December 3, 1
1996-12-03
Modified avidin-biotin technique
Grant 5,281,521 - Trojanowski , et al. January 25, 1
1994-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed